Utilization of Stable Isotope Labeling to Facilitate the Identification of Polar Metabolites of KAF156, an Antimalarial Agent.

about

Utilization of Stable Isotope Labeling to Facilitate the Identification of Polar Metabolites of KAF156, an Antimalarial Agent.

Item

http://www.wikidata.org/entity/Q49139825

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Utilization of Stable Isotope ...... KAF156, an Antimalarial Agent.

@en

Utilization of Stable Isotope ...... KAF156, an Antimalarial Agent.

@nl

type

Item

label

Utilization of Stable Isotope ...... KAF156, an Antimalarial Agent.

@en

Utilization of Stable Isotope ...... KAF156, an Antimalarial Agent.

@nl

prefLabel

Utilization of Stable Isotope ...... KAF156, an Antimalarial Agent.

@en

Utilization of Stable Isotope ...... KAF156, an Antimalarial Agent.

@nl

P1476

Utilization of Stable Isotope ...... KAF156, an Antimalarial Agent.

@en

P2093

Alexandre Catoire

http://www.w3.org/2001/XMLSchema#string

Handan He

http://www.w3.org/2001/XMLSchema#string

Hongmei Li

http://www.w3.org/2001/XMLSchema#string

James B Mangold

http://www.w3.org/2001/XMLSchema#string

Jimmy Flarakos

http://www.w3.org/2001/XMLSchema#string

Jin Zhang

http://www.w3.org/2001/XMLSchema#string

Ry R Forseth

http://www.w3.org/2001/XMLSchema#string

Su-Er W Huskey

http://www.w3.org/2001/XMLSchema#string

Tapan Ray

http://www.w3.org/2001/XMLSchema#string

Zhigang Jian

http://www.w3.org/2001/XMLSchema#string

P2860

Supporting malaria elimination with 21st century antimalarial agent drug discovery

Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery

Application of mass spectrometry for metabolite identification.

KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.

Imidazolopiperazines: lead optimization of the second-generation antimalarial agents.

Emerging artemisinin resistance in the border areas of Thailand.

A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers.

Antimalarial compounds in Phase II clinical development.

Artemisinin resistance-associated polymorphisms at the K13-propeller locus are absent in Plasmodium falciparum isolates from Haiti.

Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.

P304

1697-1708

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/DMD.116.072108

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27486238

http://www.w3.org/2001/XMLSchema#string

P921

isotopic labeling

antimalarial

stable isotope